Sheaff Brock Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-3,000
Closed -$327K – 480
2019
Q2
$327K Buy
+3,000
New +$319K 0.04% 321

Other funds holding IBB

Sheaff Brock Investment Advisors's IBB Position: Q1 2022 in Review

Sheaff Brock Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,430 shares — an estimated $218K sold.

Sheaff Brock Investment Advisors first reported a position in IBB in Q4 2015 and held it in 24 quarters. The position peaked at $570K in Q1 2017. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

  • Sheaff Brock Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
  • Sheaff Brock Investment Advisors sold 1,430 iShares Biotechnology ETF shares in Q1 2022, an estimated $218K.
  • Sheaff Brock Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 24 quarters.
  • Sheaff Brock Investment Advisors's iShares Biotechnology ETF position peaked at $570K in Q1 2017.
  • 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2022, filed 6 May 2022.